Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced the publication of a peer-reviewed Viewpoint in the European Respiratory…

Continue ReadingQureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Randomized trial demonstrates enhanced stent expansion in severely calcified coronary nodules

A randomized clinical trial at The Mount Sinai Hospital found that combining two techniques for removing calcium nodules-rotational atherectomy and intravascular lithotripsy (IVL)-before coronary stent placement allowed stents to expand…

Continue ReadingRandomized trial demonstrates enhanced stent expansion in severely calcified coronary nodules

Reducing mortality in intermediate risk pulmonary embolism through targeted mechanical thrombectomy

New research presented today at TCT 2026 and simultaneously published in JSCAI found that, in the primary analysis, mechanical thrombectomy was associated with lower short- and long-term mortality among patients…

Continue ReadingReducing mortality in intermediate risk pulmonary embolism through targeted mechanical thrombectomy